H7N9 patients show signs of resistance to oseltamivir

05/29/2013 | DoctorsLounge.com

A report in The Lancet said viral samples from three of 14 patients treated for H7N9 in a hospital in Shanghai appear to be resistant to oseltamivir. The three had mutations observed in other instances of oseltamivir resistance. The mutation may have developed in one patient after treatment with the drug, indicating that H7N9 may easily adapt, researchers said.

View Full Article in:

DoctorsLounge.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY